Cheryl Zimberlin

Direktör/Styrelseledamot på

Indi Molecular, Inc.

Commercial Services

Health Technology

Finance

Profil

Cheryl Zimberlin is currently the Director at Indi Molecular, Inc. and the Principal at Merck Ventures BV.
She previously worked as a Member-Supervisory Board at Vaximm AG.

Aktiva positioner av Cheryl Zimberlin

Företag	Position	Start
Merck Ventures BV Merck Ventures BV Investment ManagersFinance Merck Ventures invests in companies located in the Netherlands. The firm targets companies operating in the fields of healthcare, healthcare drug development, life science tools, electronics and frontier technology & sustainability sectors. It provides financing for early stage capital requirements.	Privat kapitalinvesterare	2019-04-01
Indi Molecular, Inc. Indi Molecular, Inc. BiotechnologyHealth Technology Develops a synthetic class of diagnostic and therapeutic agents	Direktör/Styrelseledamot	-

Alla aktiva positioner av Cheryl Zimberlin

Tidigare kända positioner av Cheryl Zimberlin

Företag	Position	Slut
Vaximm AG Vaximm AG Miscellaneous Commercial ServicesCommercial Services Develops immunotherapies for cancer treatment	Direktör/Styrelseledamot	-

Se detaljerna i Cheryl Zimberlins erfarenhet

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Cheryl Zimberlins erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	3
Vaximm AG Vaximm AG Miscellaneous Commercial ServicesCommercial Services Develops immunotherapies for cancer treatment	Commercial Services
Indi Molecular, Inc. Indi Molecular, Inc. BiotechnologyHealth Technology Develops a synthetic class of diagnostic and therapeutic agents	Health Technology
Merck Ventures BV Merck Ventures BV Investment ManagersFinance Merck Ventures invests in companies located in the Netherlands. The firm targets companies operating in the fields of healthcare, healthcare drug development, life science tools, electronics and frontier technology & sustainability sectors. It provides financing for early stage capital requirements.	Finance